Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7751–7800 of 18652
appointed Kevin Smith to serve as President and Chief Executive Officer ("CEO") of the Company, effective November 10, 2023.
Mr. Shabshab's role as an officer and employee of the Company ended effective November 10, 2023.
Michael A. Kuglin, who has served as the Partnership’s Chief Financial Officer since 2014 and as its Chief Accounting Officer since 2009, will continue in his role as the Partnership’s Chief Financial Officer.
Mr. Carlson notified DISH of his intention to resign as President and Chief Executive Officer of DISH effective as of November 12, 2023
On November 9, 2023, DISH Network Corporation (“DISH”) appointed Mr. Hamid Akhavan, the current Chief Executive Officer and President of EchoStar Corporation (“EchoStar”), to the additional role of President and Chief Executive Officer of DISH effective as of November 13, 2023.
On November 7, 2023, the Board of Directors of RE/MAX Holdings, Inc. (the “Company”) appointed Erik Carlson as the Company’s Chief Executive Officer, effective November 13, 2023
the Board appointed Marco Fregenal, President and Chief Financial Officer of the Company, to serve as Chief Executive Officer, in addition to his current responsibilities
Joshua Harley, the Chief Executive Officer, Director and Chairman of the Board of Directors (the “Board”) of Fathom Holdings, Inc. (the “Company”) resigned from his role as CEO and Director of the Company, effective November 13, 2023.
On November 9, 2023, Jennifer Fox, the Chief Financial Officer of Nuvation Bio Inc. (the “Company”), notified the Company of her decision to pursue a new opportunity and resign from her position at the Company effective November 27, 2023.
On November 6, 2023, Express, Inc. (the “Company”) received notice that Jason Judd, the Company’s Senior Vice President, Chief Financial Officer and Treasurer, is resigning, effective November 17, 2023, to pursue another opportunity.
Effective upon Mr. Judd’s resignation, Mark Still will serve as the Company’s Interim Chief Financial Officer and Treasurer, in addition to his current role as Senior Vice President, Brand Finance and Planning & Allocation, reporting to Stewart Glendinning, the Company’s Chief Executive Officer.
Robert M. Patterson, Chairman of the Board of Directors and the President and Chief Executive Officer of Avient Corporation (the “Company”), notified the Board of Directors (the “Board”) of the Company that he will retire as President and Chief Executive Officer and as a member of the Board, effective as of December 1, 2023.
On November 13, 2023, the Company announced that, in connection with Mr. Patterson’s retirement, Dr. Ashish Khandpur has been appointed as President and Chief Executive Officer and a member of the Board, effective December 1, 2023.
the Board approved the appointment of Bruce Culleton, MD, as Chief Executive Officer and as a Class III director of the Company, effective as of the Effective Date.
the board of directors (the “Board”) of ProKidney Corp. (the “Company”) approved the termination, without cause, of Tim Bertram, Ph.D., Chief Executive Officer of the Company, effective November 15, 2023
Joseph J. Sarret, M.D., J.D., CohBar’s President and Chief Executive Officer, at the direction of the Board, ceased to be an officer of CohBar, effective as of November 10, 2023.
Jeffery F. Biunno, CohBar’s Chief Financial Officer, at the direction of the Board, ceased to be an officer of CohBar, effective as of November 10, 2023.
Dave Boennighausen ceased serving as Chief Executive Officer of the Company, effective November 9, 2023.
appointed Drew Madsen, 67, as t he Company’s interim Chief Executive Officer, effective immediately.
Chief Financial Officer Appointment Effective November 13, 2023, the Company appointed Steven G. Crane, age 66, as its Chief Financial Officer.
Ian McAdams, previously the interim Co-Chief Financial Officer of the Company, has been named Chief Financial Officer of the Company.
On November 7, 2023, Sebastian Holl notified the Board of Directors (the “Board”) of Global AI, Inc. (the “Company”) of his resignation as Interim Chief Executive Officer of the Company, effective as of November 1, 2023.
Effective November 1, 2023, Abhinav “Abe” Somani was appointed as Chief Executive Officer of the Company.
Andrew Stanleick, who will step down from the role of chief executive officer of the Company, effective as of November 19, 2023.
the Board of Directors (the “Board”) of The Beauty Health Company (the “Company”) appointed Marla Beck, age 53, as interim chief executive officer of the Company (the “Interim CEO”), for a 6-month term (the “Term”) effective November 20, 2023
appointed Vanessa Guzmán-Clark, 43, as the Company’s Chief Financial Officer, effective November 7, 2023.
(b) Departure of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
Effective November 7, 2023, James B. Frakes, Chief Financial Officer of Aethlon Medical, Inc. (the “Company”), was appointed as (i) Interim Chief Executive Officer of the Company, replacing Charles J. Fisher, Jr. M.D., and (ii) a member of the Board of Directors of the Company (the “Board”).
On November 6, 2023, the Company also appointed Mr. Rajeev Gopala Krishna Nair as its Chief Financial Officer, effective as of November 6, 2023.
Effective as of November 6, 2023, the following individuals were appointed as officers of the Company: Mr. Sudhir Appukuttan Panikassery as the Chief Executive Officer and Mr. Bhisham (Ajay) Khare as the Chief Revenue Officer & Chief Operating Officer ( Americas), among other officers.
Christopher Walters, the Chief Executive Officer of the Company, announced that, subject to the closing of the Merger, he plans to step down from the role of Chief Executive Officer after the end of 2023
Marc Mehlman, the Company’s Chief Financial Officer and Treasurer, and Tabitha Bailey, the Company’s Chief Legal Officer and Corporate Secretary, announced that, subject to the closing of the transactions contemplated by the Merger Agreement, they would not remain with the Company long-term following such closing.
On November 6, 2023, the Board of Directors (the “Board”) of Marpai, Inc. (the “Company”) appointed Damien Lamendola, age 66, to serve as the Chief Executive Officer (the “CEO”) of the Company.
Effective November 6, 2023, Steve Johnson, age 53, was appointed to serve as the Company’s Chief Financial Officer (the “CFO”).
On November 6, 2023, the Board dismissed Yoram Bibring as the Company’s CFO.
On November 6, 2023, the Board dismissed Edmundo Gonzalez as the CEO of the Company.
On November 6, 2023, the board of directors (the “Board”) of the registrant appointed Scott C. Lem, age 45, as Chief Financial Officer, effective as of February 15, 2024.
Concurrently with Mr. Lem’s appointment, Penni F. Roll announced that she will step down as Chief Financial Officer of the registrant, effective as of February 15, 2024.
the Board of Directors of Metropolitan Holding Corp. (the “Company”), the holding company for Metropolitan Commercial Bank (the “Bank”), appointed Mr. Daniel Dougherty, age 62, to the positions of Executive Vice President and Chief Financial Officer of the Company
On November 6, 2023, MarketAxess Holdings Inc. (the “Company”) was informed by Christopher N. Gerosa, the Company’s Chief Financial Officer, that he will resign from such position effective January 31, 2024, to accept a position with another company.
The Company has appointed the Company’s President, J. Michael McGillis, who previously served as the Company’s chief financial officer until March 2022, as chief financial officer, effective upon Mr. Agarwal’s departure from the Company on November 17, 2023.
Jai Agarwal notified Claros Mortgage Trust, Inc. (the “Company”) of his decision to resign as chief financial officer of the Company, effective as of November 17, 2023.
the appointments of Rick Gaenzle as Chief Executive Officer, John Stanfield as Chief Financial Officer and Secretary, Scott Honour as Chairman of the Board, and Tao Tan as President
each of the Company’s then-current officers, Sunny S. Shah, Thomas M. Boehlert and Rebecca Coffelt, resigned as Chief Executive Officer, Chief Financial Officer, and Secretary, respectively
the appointments of Rick Gaenzle as Chief Executive Officer, John Stanfield as Chief Financial Officer and Secretary, Scott Honour as Chairman of the Board, and Tao Tan as President
each of the Company’s then-current officers, Sunny S. Shah, Thomas M. Boehlert and Rebecca Coffelt, resigned as Chief Executive Officer, Chief Financial Officer, and Secretary, respectively
On November 8, 2023, Justin C. Clausen (age 36), who currently serves as Chief Accounting Officer of the Company, was appointed to the role of Chief Financial Officer effective July 5, 2024
On November 8, 2023, John L. Pierschbacher, who currently serves as the principal financial and accounting officer of Ames National Corporation (the “Company”), notified the Company of his intent to retire as Chief Financial Officer of the Company effective July 5, 2024.
On November 4, 2023, Jeff Whiteside notified eXp World Holdings, Inc. (the “Company”) that he will be resigning as Chief Financial Officer and Chief Collaboration Officer of the Company, effective as of December 1, 2023.
the Board of Directors of the Company has appointed Jian “Kent” Cheng, the Company’s Chief Accounting Officer, to assume the additional role of principal financial officer, effective as of the Effective Date
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.